National Healthcare CORP

National HealthCare Corporation (NHC) has finalized the acquisition of 35 healthcare facilities from National Health Investors, Inc. (NHI) for $560 million, aiming for long-term investor returns and operational control.

National HealthCare Corporation has entered into a new $525 million credit agreement to finance the acquisition of assets from National Health Investors.

National HealthCare Corporation shareholders re-elected directors and approved executive compensation at the May 7, 2026 Annual Meeting.

National HealthCare Corporation reported a 2.2% increase in net operating revenue and a 21.1% rise in adjusted net income for the first quarter of 2026.

National HealthCare Corporation announced significant revenue and net income growth for the year ended December 31, 2025, driven by organic growth and a key acquisition.

National HealthCare Corporation appointed Dr. David Gifford and Mr. Andrew Adams to its Board of Directors, increasing the board size to nine members.

National HealthCare Corporation reported strong first-quarter 2026 results, with net income attributable to NHC stockholders increasing to $35.9 million, driven by revenue growth and improved operating margins.

National HealthCare Corporation reported significant operational revenue and income growth for Q3 and 9M 2025, driven by increased census and reduced staffing costs, despite a decline in GAAP net income due to lower unrealized gains on securities and an ongoing lease dispute with NHI.

National HealthCare Corporation reports significant revenue and operational income growth for Q2 and H1 2025, driven by acquisitions and improved census, despite a GAAP net income dip due to unrealized investment losses.

National HealthCare Corporation's Q1 2025 results showcase significant revenue growth and improved profitability, boosted by the White Oak acquisition and increased skilled nursing facility census.

National HealthCare Corporation (NHC) reported a significant increase in net income for the third quarter of 2024, driven by strategic acquisitions and improved operational efficiencies.

National HealthCare Corporation (NHC) announced positive second-quarter results, marked by increased revenue and strategic acquisitions, according to their latest 10-Q filing.

National HealthCare Corporation reported a significant increase in net operating revenues and net income for fiscal year 2025, driven by strategic acquisitions and improved skilled nursing census.

National HealthCare Corporation's 2024 financial results show significant growth, primarily driven by the acquisition of White Oak Senior Living and improvements in operational efficiency.

National HealthCare Corporation's 2024 results show significant revenue growth and improved profitability, primarily driven by the acquisition of White Oak Senior Living and enhanced operational efficiencies.

National HealthCare Corporation's 10-K filing details its insider trading policy, 2023 financial results, and operational performance across its healthcare segments.

Brian F. Kidd, SVP and CFO of National Healthcare Corp (NHC), reported a transaction involving the acquisition of 500 shares of common stock.

Director Emil E. Hassan reported a transaction involving National Healthcare Corp (NHC) common stock on June 16, 2026.

National HealthCare Corp director Robert Adams exercised 4,000 stock options and subsequently transferred the shares via gift.

Director Lisa Piercey of National Healthcare Corp reported transactions involving common stock and stock options, including a correction to previously filed exercise expiration dates.

Ben Anderson Flatt, Senior VP & CIO of National HealthCare Corp, reported significant stock option activity and share acquisitions/dispositions on May 22, 2026.

National Healthcare Corp director and 10% owner Richard F. LaRoche Jr. reported selling 7,500 shares of common stock.

National HealthCare Corporation schedules its 2026 Annual Meeting for May 7, 2026, to address director elections and executive compensation.

National HealthCare Corporation (NHC) will hold its 2025 Annual Meeting of Shareholders on May 8, 2025, to vote on director re-elections, executive compensation, and other business matters.

National HealthCare Corporation (NHC) will hold its 2024 Annual Meeting of Shareholders on May 9, 2024, to vote on director re-elections and executive compensation.

First Trust Portfolios L.P., First Trust Advisors L.P., and The Charger Corporation have jointly filed a Schedule 13G, reporting beneficial ownership of 5.09% of National HealthCare Corporation's common stock.

Vanguard Portfolio Management has reported beneficial ownership of 794,305 shares, representing 5.11% of the outstanding common stock of National HealthCare Corp.

The Vanguard Group has filed an amended Schedule 13G, reporting a 0% beneficial ownership in National HealthCare Corp following an internal realignment.

Morgan Stanley and its subsidiary have disclosed a significant beneficial ownership stake of 7.1% in National Healthcare Corp common stock as of December 31, 2025.

BlackRock, Inc. has reported an increased beneficial ownership of 11.6% in National Healthcare Corp's common stock, totaling 1,800,345 shares.

The Vanguard Group has filed an amended Schedule 13G, reporting a 9.19% beneficial ownership stake in National HealthCare Corp as of March 31, 2025.